Innovative Technology GattaCo's development of a disposable, fully automatic centrifuge replacement tool, Sípon, presents a significant opportunity to target diagnostic labs, clinics, and telemedicine providers seeking cost-effective, rapid blood testing solutions with high ease of use.

Strategic Partnerships Recent collaborations with GenScript and the University of California Riverside indicate potential for selling integrated testing platforms and leveraging academic and biotech partnerships to expand market reach.

Leadership and Growth With new executive leadership and a seed funding round led by IRA Capital, there is a strong focus on scaling commercialization efforts, making the company an attractive prospect for strategic investments and enterprise sales in diagnostics.

Market Expansion GattaCo’s technology enables diagnostics providers and laboratories to offer advanced testing directly to consumers and health systems globally, creating opportunities to penetrate at-home testing markets and telehealth service providers.

Emerging Product Line The launch of the A-PON plasma separation tool and ongoing development of blood analysis cartridge systems suggest a growing pipeline of products ready to serve hospitals, clinics, and health agencies needing portable, high-quality blood testing solutions.